P.07.1 SWITCHING FROM INFLIXIMAB ORIGINATOR TO A FIRST BIO SIMILAR IS SAFE AND EFFECTIVE. A SINGLE CENTER SERIES WITH THROUGH LEVELS AND ANTI-DRUG ANTIBODIES DETERMINATION
Digestive and Liver Disease(2018)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要